Report Code: TIPBT00002546 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
The scientific examination of the effects of harmful chemical agents on engineered bacteria or mammalian cells is known as in vitro toxicity testing . In the early stages of the discovery of potentially beneficial novel compounds such as therapeutic medications, organic products, and food additives, in vitro toxicity monitoring approaches are used mainly to classify potentially dangerous chemicals and/or to demonstrate the absence of certain toxic properties.
The "Global In Vitro Toxicology Testing Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the In Vitro Toxicology Testing market with detailed market segmentation by product and service, toxicity endpoints and tests, technology, method, application and geography. The report provides key statistics on the market status of the leading In Vitro Toxicology Testing market players and offers key trends and opportunities in the market.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The In Vitro Toxicology Testing market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the In Vitro Toxicology Testing market in these regions.
The human response to the coronavirus pandemic is being led by innovative biopharmaceutical companies. Several global biotech firms are working to characterise the Sars-Cov-2 genome and create a vaccine against it. In contrast to the response to SARS/MERs, biotech companies are investigating SARs-Cov-2 at breakneck speed, investing considerable resources in R&D. With several candidates in clinical trials, the public and private sectors are expected to work together in the near future, at least until a Covid-19 vaccine is created.
The report covers key developments in the In Vitro Toxicology Testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from In Vitro Toxicology Testing market are anticipated to lucrative growth opportunities in the future with the rising demand for In Vitro Toxicology Testing in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the In Vitro Toxicology Testing market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
The List of Companies
1. Covance, Inc. (A part of Laboratory Corporation of America Holdings)
2. Bio-Rad Laboratories, Inc.
4. General Electric
5. Eurofins Scientific
6. Merck KGaA
7. Thermo Fisher Scientific, Inc
8. Charles River
9. Catalent, Inc
10. Promega Corporation.
12. SGS S.A.